High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
A defense analyst warned that China may be watching gleefully as the Pentagon scrambles to restock two weapons classes critical to any future great-power fight. Four defense contractors sit at the center of a procurement surge that may arrive too slowly to matter.
Corning, Cisco Systems, and Texas Instruments are repositioning around AI infrastructure needs, showing earnings growth, steady margins, dividends, and Moderate Buy analyst ratings with notable upside targets.
Retail sales jumped 1.2% in August despite inflation, spotlighting five retailers with strong online presence and improving earnings estimates.
Cathie Wood's ARK Invest firm on Tuesday bought $25 million shares of Rocket Lab stock. Analyst praises revenue opportunities.
Archer Aviation Gets Major Midnight Boost as Air Taxi Tour Expands
AMD just crossed a trillion-dollar market cap and the sell side is scrambling to rewrite its models in real time, but the gap between the bulls racing to raise targets and the bears warning of a blow-off top has never been wider.
The global electric vehicle (EV) Battery Management System (BMS) Signal Transformer Market is experiencing significant growth, driven by the increasing adoption of high-voltage platforms and the demand for faster charging technologies. This market is projected to reach USD 2.19 billion by 2032, expanding at a compound annual growth rate (CAGR) of 17.77%. As electric vehicles integrate larger battery packs and more advanced charging features, the importance of signal transformers in ensuring...
Key Stats for Microsoft StockPrice change for Microsoft stock in last 6 months: 30%$MSFT Stock Price as of Sep. 22: $49852-Week High: $554$MSFT Stock Price Target: $576What Happened?Oppenheimer raised its price target on Microsoft (MSFT) stock to $570 from $515 on Tuesday, keeping its Outperform rating in place.
Key Stats for Amgen StockPrice change for Amgen stock in last 1 year: 43%$AMGN Stock Price as of Sep. 22: $41052-Week High: $447$AMGN Stock Price Target: $388What Happened?Amgen (AMGN) stock rose after the company shared positive Phase 3 trial results.
Key Stats for SoFi StockPrice change for SoFi stock in the last 1 year: -41%$SOFI Stock Price as of Sep. 22: $1752-Week High: $33$SOFI Stock Price Target: $20What Happened?SoFi Technologies (SOFI) stock rose 3% on Tuesday.
Chipotle Mexican Grill Inc (NYSE:CMG) spent this summer doing damage control, including removing affected jalapeños from restaurants after they were linked to a salmonella outbreak, while the broader restaurant industry faced a cyclospora outbreak linked to iceberg lettuce, and navigating a landscape that’s seen over 12,800 illnesses caused by foodborne outbreaks in the US. Now […]
Netflix and Airbnb could see meaningful earnings growth, delivering compounding returns.
Voyager Technologies Shares Slide After Massive Debt Offering
It's been a rough run for Netflix stock.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how FuelCell Energy (NASDAQ:FCEL) and the rest of the renewable energy stocks fared in Q2.
Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical readouts.
According to Wells Fargo, Micron’s next phase of growth will depend on confidence in the duration of memory tightness.
Retail investors in Brazil are piling into exchange-traded funds at a record pace as a wave of new products broadens the market.
CRISPR Therapeutics owns the only approved gene therapy of its kind, yet the stock sits far below where Wall Street thinks it belongs. One analyst sees a path to gains that would embarrass the broader market, but the numbers tell a complicated story.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Celsius (NASDAQ:CELH) and its peers.
Major US stock market indexes were slightly lower in Wednesday's premarket trading as investors focu
Verizon could spend up to $20 billion in a 2027 spectrum auction, says analyst, while SpaceX participates cautiously amid Starlink expansion.
News of the day for Sept. 23, 2026
Burry added to short positions in Micron, Nebius, Palantir and the iShares Semiconductor ETF.
D-Wave Quantum (QBTS) trades near $17.50, about 61% below the high it set inside the past year. Nothing in the market broke to do that. The S&P 500 returned close to 18% over the same twelve months. The stock has already fallen a shock-sized amount without a shock, which is what makes the next leg hard to size.
JDEAX, JICAX, JHUKX and JSVRX offer diversified exposure across U.S. equities, emerging markets and small-cap value amid market volatility.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.